Literature DB >> 23115279

Epigenetic silencing of antiviral genes renders clones of Huh-7 cells permissive for hepatitis C virus replication.

Qiuyue Chen1, Bray Denard, Hua Huang, Jin Ye.   

Abstract

Hepatitis C virus (HCV) does not replicate efficiently in wild-type human hepatoma Huh-7 cells, but it replicates robustly in certain subclones of Huh-7 cells. Previously, we demonstrated that silencing of cyclic AMP (cAMP) response element binding protein 3-like 1 (CREB3L1), a cellular transcription factor that inhibits HCV replication, allows HCV to replicate in HRP1 cells, a subclone of Huh-7 cells permissive for HCV replication. Here we show that silencing of myxovirus resistant 1 (MX1), a known interferon-induced antiviral gene, is responsible for HRP4 cells, another subclone of Huh-7 cells, being permissive for HCV replication. Both CREB3L1 and MX1 are epigenetically silenced through DNA methylation in HRP1 and HRP4 cells, respectively. We further demonstrate that Huh-7 cells exist as a mixed population of cells with distinct patterns of gene methylation and HCV replicates in subpopulations of Huh-7 cells that have antiviral genes epigenetically silenced by DNA hypermethylation. Our results demonstrate that understanding the mechanism through which subclones of Huh-7 cells become permissive for HCV replication is crucial for studying their interaction with HCV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115279      PMCID: PMC3536425          DOI: 10.1128/JVI.01984-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.

Authors:  Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells.

Authors:  Michael Weber; Jonathan J Davies; David Wittig; Edward J Oakeley; Michael Haase; Wan L Lam; Dirk Schübeler
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

3.  Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins.

Authors:  Hua Huang; Fang Sun; David M Owen; Weiping Li; Yan Chen; Michael Gale; Jin Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

4.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

6.  Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.

Authors:  Frank Scholle; Kui Li; Francis Bodola; Masanori Ikeda; Bruce A Luxon; Stanley M Lemon
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells.

Authors:  Kazuhito Naka; Ken-ichi Abe; Kazunori Takemoto; Hiromichi Dansako; Masanori Ikeda; Kunitada Shimotohno; Nobuyuki Kato
Journal:  J Hepatol       Date:  2006-02-28       Impact factor: 25.083

8.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

9.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model.

Authors:  Rhea Sumpter; Chunfu Wang; Eileen Foy; Yueh-Ming Loo; Michael Gale
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more
  9 in total

1.  OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.

Authors:  Michael Rose; Claudia Schubert; Laura Dierichs; Nadine T Gaisa; Matthias Heer; Axel Heidenreich; Ruth Knüchel; Edgar Dahl
Journal:  Epigenetics       Date:  2014-12       Impact factor: 4.528

Review 2.  Roles of regulated intramembrane proteolysis in virus infection and antiviral immunity.

Authors:  Jin Ye
Journal:  Biochim Biophys Acta       Date:  2013-12

Review 3.  Doxorubicin, DNA torsion, and chromatin dynamics.

Authors:  Fan Yang; Sheila S Teves; Christopher J Kemp; Steven Henikoff
Journal:  Biochim Biophys Acta       Date:  2013-12-19

4.  Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome.

Authors:  Bray Denard; Andrea Pavia-Jimenez; Weina Chen; Noelle S Williams; Harris Naina; Robert Collins; James Brugarolas; Jin Ye
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

5.  Epigenetic Suppression of Interferon Lambda Receptor Expression Leads to Enhanced Human Norovirus Replication In Vitro.

Authors:  Sabastine E Arthur; Frédéric Sorgeloos; Myra Hosmillo; Ian G Goodfellow
Journal:  mBio       Date:  2019-10-01       Impact factor: 7.867

6.  Determining the cellular diversity of hepatitis C virus quasispecies by single-cell viral sequencing.

Authors:  E Carol McWilliam Leitch; John McLauchlan
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 7.  Exploiting tumor epigenetics to improve oncolytic virotherapy.

Authors:  Nicole E Forbes; Hesham Abdelbary; Mathieu Lupien; John C Bell; Jean-Simon Diallo
Journal:  Front Genet       Date:  2013-09-20       Impact factor: 4.599

Review 8.  Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.

Authors:  Nicole E Forbes; Ramya Krishnan; Jean-Simon Diallo
Journal:  Front Oncol       Date:  2014-07-23       Impact factor: 6.244

9.  CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.

Authors:  Bray Denard; Sharon Jiang; Yan Peng; Jin Ye
Journal:  BMC Cancer       Date:  2018-08-13       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.